DcR3-TL1A signalling inhibits cytokine-induced proliferation of rheumatoid synovial fibroblasts

International Journal of Molecular Medicine

Volumn 28, Issue 3, 2011, Pages 423-427

  Takahashi, Masayasu ^a   Miura, Yasushi ^a,b   Hayashi, Shinya ^a   Tateishi, Koji ^a   Fukuda, Koji ^a   Kurosaka, Masahiro ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KOBE UNIVERSITY   (Japan)

Author keywords

Decoy receptor 3; Reverse signalling; Rheumatoid synovial fibroblast; TL1A

Indexed keywords

CYTOKINE; DECOY RECEPTOR 3; TL1A PROTEIN; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BINDING AFFINITY; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FIBROBLAST; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; MACROPHAGE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; RHEUMATOID SYNOVIAL FIBROBLAST; SIGNAL TRANSDUCTION; SYNOVIUM;

APOPTOSIS; ARTHRITIS, RHEUMATOID; BLOTTING, WESTERN; CELL PROLIFERATION; FIBROBLASTS; HUMANS; INTERLEUKIN-1BETA; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 6B; RNA, MESSENGER, STORED; SIGNAL TRANSDUCTION; SYNOVIAL MEMBRANE; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 15; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79959939605     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2011.687     Document Type: Article

References (36)

1. Chou CT, Yang JS and Lee MR: Apoptosis in rheumatoid arthritis - expression of Fas, Fas-L, p53, and Bcl-2 in rheumatoid synovial tissues. J Pathol 193: 110-116, 2001.
2. Tak PP, Zvaifler NJ, Green DR and Firestein GS: Rheumatoid arthritis and p53: how oxidative stress might alter the course of inflammatory diseases. Immunol Today 21: 78-82, 2000. (Pubitemid 30069620)
3. Yamanishi Y, Boyle DL, Rosengren S, Green DR, Zvaifler NJ and Firestein GS: Regional analysis of p35 mutations in rheumatoid arthritis synovium. Proc Natl Acad Sci USA 99: 10025-10030, 2002. (Pubitemid 34831166)
4. Hayashi S, Miura Y, Nishiyama T, et al: Decoy receptor 3 expressed in rheumatoid synovial fibroblasts protects the cells against Fas-induced apoptosis. Arthritis Rheum 56: 1067-1075, 2007. (Pubitemid 46608631)
5. Pitti RM, Marsters SA, Lawrence DA, et al: Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer. Nature 396: 699-703, 1998. (Pubitemid 29003951)
6. Bai C, Connolly B, Metzker ML, et al: Overexpression of M68/ DcR3 in human gastrointestinal tract tumors independent of gene amplification and its location in a four-gene cluster. Proc Natl Acad Sci USA 97: 1230-1235, 2000. (Pubitemid 30080841)
7. Ohshima K, Haraoka S, Sugihara M, et al: Amplification and expression of a decoy receptor for Fas ligand (DcR3) in virus (EBV or HTLV-I) associated lymphomas. Cancer Lett 160: 89-97, 2000.
8. Chen JG, Zhang LR and Kim S: Quantification and detection of DcR3, a decoy receptor in TNFR family. J Immun Methods 285: 63-70, 2004.
9. Shi G, Wu Y, Zhang J and Wu J: Death decoy receptor TR6/ DcR3 inhibits T cell Chemotaxis in vitro and in vivo. J Immunol 171: 3407-3414, 2003. (Pubitemid 37254541)
10. Yu KY, Kwon B, Ni J Zhai YF, Ebner R and Kwon BS: A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis. J Biol Chem 274: 13733-13736, 1999.
11. Migone TS, Zhang J, Luo X, et al: TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator. Immunity 16: 479-492, 2002. (Pubitemid 34260924)
12. Yang CR, Wang JH, Hsieh SL, Wang SM, Hsu TL and Lin WW: Decoy receptor 3 (DcR3) induces osteoclast formation from monocyte/macrophage lineage precursor cells. Cell Death Differ 11 (Suppl 1): S97-S107, 2004. (Pubitemid 39136802)
13. Hsu MJ, Lin WW, Tsao WC, et al: Enhanced adhesion of monocytes via reverse signaling triggered by decoy receptor 3. Exp Cell Res 292: 241-251, 2004.
14. Cassatella MA, Pereira-da-Silva G, Tinazzi I, et al: Soluble TNF-like cytokine (TL1A) production by immune complexes stimulated monocytes in rheumatoid arthritis. J Immunol 178: 7325-7333, 2007. (Pubitemid 46847460)
15. Kim WJ, Kang YJ, Koh EM, Ahn KS, Cha HS and Lee WH: LIGHT is involved in the pathogenesis of rheumatoid arthritis by inducing the expression of pro-inflammatory cytokines and MMP-9 in macrophages. Immunology 114: 272-279, 2005.
16. Telegina E, Reshetnyak T, Moshnikova A, et al: A possible role of Fas-ligand-mediated 'reverse signaling' in pathogenesis of rheumatoid arthritis and systemic lupus erythematosus. Immunol Lett 122: 12-17, 2009.
17. Arnett FC, Edworthy SM, Bloch DA, et al: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31: 315-324, 1988.
18. Ishiyama M, Miyazono Y, Sasamoto K, Ohkura Y and Ueno K: A highly water-soluble disulfonated tetrazolium salt as a chromogenic indicator for NADH as well as cell viability. Talanta 44: 1299-1305, 1997. (Pubitemid 27249311)
19. Maekawa Y, Yagi K, Nonomura A, et al: A tetrazolium-based colorimetric assay for metabolic activity of stored blood platelets. Thromb Res 109: 307-314, 2003. (Pubitemid 36724826)
20. Rioja I, Bush KA, Buckton JB, Dickson MC and Life PF: Joint cytokine quantification in two rodent arthritis models: kinetics of expression, correlation of mRNA and protein levels and response to prednisolone treatment. Clin Exp Immunol 137: 65-73, 2004. (Pubitemid 38869779)
21. Overbergh L, Giulietti A, Valckx D, Decallonne R, Bouillon R and Mathieu C: The use of real-time reverse transcriptase PCR for the quantification of cytokine gene expression. J Biomol Tech 14: 33-43, 2003.
22. Harris ED Jr: Rheumatoid arthritis. Pathophysiology and implications for therapy. N Engl J Med 322: 1277-1289, 1990.
23. Nakajima T, Aono H, Hasunuma T, et al: Apoptosis and functional Fas antigen in rheumatoid arthritis synoviocytes. Arthritis Rheum 38: 485-491, 1995.
24. Firestein GS, Yeo M and Zvaifler NJ: Apoptosis in rheumatoid arthritis synovium. J Clin Invest 96: 1631-1638, 1995.
25. Hoa TT, Hasunuma T, Aono H, et al: Novel mechanisms of selective apoptosis in synovial T cells of patients with rheumatoid arthritis. J Rheumatol 23: 1332-1337, 1996. (Pubitemid 26258754)
26. Tateishi K, Miura Y, Hayashi S, Takahashi M and Kurosaka M: DcR3 protects THP-1 macrophages from apoptosis by increasing integrin alpha4. Biochem Biophys Res Commun 389: 593-598, 2009.
27. Chang YC, Hsu TL, Lin HH, et al: Modulation of macrophage differentiation and activation by decoy receptor 3. J Leukoc Biol 75: 486-494, 2004.
28. You RI, Chang YC, Chen PM, et al: Apoptosis of dendritic cells induced by decoy receptor 3 (DcR3). Blood 111: 1480-1488, 2008.
29. Tang CH, Hsu TL, Lin WW, et al: Attenuation of bone mass and increase of osteoclast formation in decoy receptor 3 transgenic mice. J Biol Chem 282: 2346-2354, 2007.
30. Connolly K, Cho YH, Duan R, et al: In vivo inhibition of Fas ligand-mediated killing by TR6, a Fas ligand decoy receptor. J Pharmacol Exp Ther 298: 25-33, 2001.
31. Bamias G, Siakavellas SI, Stamatelopoulos KS, Chryssochoou E, Papamichael C and Sfikakis PP: Circulating levels of TNF-like cytokine 1A (TL1A) and its decoy receptor 3 (DcR3) in rheumatoid arthritis. Clin Immunol 129: 249-255, 2008.
32. Zhang J, Wang X, Fahmi H, et al: Role of TL1A in the pathogenesis of rheumatoid arthritis. J Immunol 183: 5350-5357, 2009.
33. Bull MJ, Williams AS, Mecklenburgh Z, et al: The death receptor 3-TNF-like protein 1A pathway drives adverse bone pathology in inflammatory arthritis. J Exp Med 205: 2457-2464, 2008.
34. Bamias G, Martin C III, Marini M, et al: Expression, localization, and functional activity of TL1A, a novel Th1-polarizing cytokine in inflammatory bowel disease. J Immunol 171: 4868-4874, 2003. (Pubitemid 37310609)
35. Bamias G, Mishina M, Nyce M, et al: Role of TL1A and its receptor DR3 in two models of chronic murine ileitis. Proc Natl Acad Sci USA 103: 8441-8446, 2006. (Pubitemid 43838474)
36. Bayry J: Immunology: TL1A in the inflammatory network in autoimmune diseases. Nat Rev Rheumatol 6: 67-68, 2010.